doi: 10.1007/BF01922409.
The history of cyclosporin A (Sandimmune) revisited: another point of view
- PMID: 8575558
- DOI: 10.1007/BF01922409
Item in Clipboard
The history of cyclosporin A (Sandimmune) revisited: another point of view
Experientia.
.
Abstract
The immunosuppressant cyclosporin A (Sandimmune) has become the first line treatment for preventing rejection of transplanted organs and for certain autoimmune diseases. The discovery of that drug and its preclinical development are described, and it is shown that most earlier accounts of the history of this compound are, in important respects, incorrect and misleading.
Similar articles
-
History of the discovery of cyclosporin and of its early pharmacological development.Wien Klin Wochenschr. 2002 Jun 28;114(12):433-7. Wien Klin Wochenschr. 2002. PMID: 12422576 No abstract available.
-
The controversial early history of cyclosporin.Swiss Med Wkly. 2001 Jun 2;131(21-22):299-302. doi: 10.4414/smw.2001.09702. Swiss Med Wkly. 2001. PMID: 11584691
-
Cyclosporin and the clinical investigator.Nat Med. 1997 Jun;3(6):590. doi: 10.1038/nm0697-590a. Nat Med. 1997. PMID: 9176474 No abstract available.
-
Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A.Clin Transplant. 2013 May-Jun;27(3):326-9. doi: 10.1111/ctr.12072. Epub 2013 Jan 20. Clin Transplant. 2013. PMID: 23331048 Review.
-
A few steps along the path to adult transplantation tolerance.Transplant Proc. 1999 Feb-Mar;31(1-2A):11S-13S. doi: 10.1016/s0041-1345(99)00002-0. Transplant Proc. 1999. PMID: 10078219 Review. No abstract available.
Cited by
-
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development.ACS Mater Au. 2023 Aug 21;3(6):600-619. doi: 10.1021/acsmaterialsau.3c00032. eCollection 2023 Nov 8. ACS Mater Au. 2023. PMID: 38089666 Free PMC article. Review.
-
Expanding the limits of isonitrile-mediated amidations: on the remarkable stereosubtleties of macrolactam formation from synthetic seco-cyclosporins.J Am Chem Soc. 2012 Feb 1;134(4):2378-84. doi: 10.1021/ja2103372. Epub 2012 Jan 17. J Am Chem Soc. 2012. PMID: 22280518 Free PMC article.
-
Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool.Mar Drugs. 2021 May 27;19(6):311. doi: 10.3390/md19060311. Mar Drugs. 2021. PMID: 34072121 Free PMC article. Review.
-
Non-Immunosuppressive Cyclophilin Inhibitors.Angew Chem Int Ed Engl. 2022 Sep 26;61(39):e202201597. doi: 10.1002/anie.202201597. Epub 2022 Aug 19. Angew Chem Int Ed Engl. 2022. PMID: 35290695 Free PMC article. Review.
-
Identifying Genetic Signatures Associated with Oncogene-Induced Replication Stress in Osteosarcoma and Screening for Potential Targeted Drugs.Biochem Genet. 2024 Jun;62(3):1690-1715. doi: 10.1007/s10528-023-10497-4. Epub 2023 Sep 6. Biochem Genet. 2024. PMID: 37672187